INR 57.44
(2.85%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 100.3 Million INR | 43.61% |
2022 | 69.84 Million INR | 33.91% |
2021 | 52.15 Million INR | 44.55% |
2020 | 36.08 Million INR | 198.85% |
2019 | 12.07 Million INR | -6.58% |
2018 | 12.92 Million INR | -48.14% |
2017 | 24.92 Million INR | -20.31% |
2016 | 31.27 Million INR | 26.29% |
2015 | 24.76 Million INR | 40.17% |
2014 | 17.66 Million INR | 12.42% |
2013 | 15.71 Million INR | 41.39% |
2012 | 11.11 Million INR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 20.58 Million INR | -47.33% |
2023 Q3 | 22.85 Million INR | -3.52% |
2023 Q4 | 39.08 Million INR | 71.0% |
2023 FY | 100.3 Million INR | 43.61% |
2023 Q1 | 17.4 Million INR | -28.57% |
2023 Q2 | 23.68 Million INR | 36.07% |
2022 Q4 | 24.37 Million INR | -8.08% |
2022 Q3 | 26.51 Million INR | 6.79% |
2022 Q2 | 24.82 Million INR | 419.69% |
2022 Q1 | -7.76 Million INR | -133.32% |
2022 FY | 69.84 Million INR | 33.91% |
2021 Q4 | 23.3 Million INR | 35.79% |
2021 Q1 | 4.41 Million INR | -19.91% |
2021 Q2 | 24.93 Million INR | 465.07% |
2021 Q3 | 17.16 Million INR | -31.16% |
2021 FY | 52.15 Million INR | 44.55% |
2020 Q2 | 12.44 Million INR | 0.0% |
2020 Q4 | 5.5 Million INR | 0.0% |
2020 Q3 | 5.5 Million INR | -55.72% |
2020 Q1 | 12.44 Million INR | 508.87% |
2020 FY | 36.08 Million INR | 198.85% |
2019 Q3 | 2.04 Million INR | -47.47% |
2019 Q1 | 3.89 Million INR | -60.65% |
2019 FY | 12.07 Million INR | -6.58% |
2019 Q4 | 2.04 Million INR | 0.0% |
2019 Q2 | 3.89 Million INR | 0.0% |
2018 Q4 | 9.88 Million INR | 0.0% |
2018 FY | 12.92 Million INR | -48.14% |
2018 Q3 | 9.88 Million INR | 2845.86% |
2018 Q1 | -360 Thousand INR | -104.48% |
2018 Q2 | -360 Thousand INR | 0.0% |
2017 FY | 24.92 Million INR | -20.31% |
2017 Q1 | 5.94 Million INR | 0.0% |
2017 Q2 | 5.94 Million INR | 0.0% |
2017 Q3 | 8.03 Million INR | 35.34% |
2017 Q4 | 8.03 Million INR | 0.0% |
2016 FY | 31.27 Million INR | 26.29% |
2015 FY | 24.76 Million INR | 40.17% |
2014 FY | 17.66 Million INR | 12.42% |
2013 FY | 15.71 Million INR | 41.39% |
2012 FY | 11.11 Million INR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 5.75 Billion INR | 98.258% |
Aurobindo Pharma Limited | 42.2 Billion INR | 99.762% |
Glenmark Life Sciences Limited | 8.97 Billion INR | 98.883% |
Granules India Limited | 6.81 Billion INR | 98.529% |
Indoco Remedies Limited | 1.29 Billion INR | 92.24% |
Achyut Healthcare Limited | 4.43 Million INR | -2160.027% |
Ajanta Pharma Limited | 19.67 Billion INR | 99.49% |
Alkem Laboratories Limited | 19.46 Billion INR | 99.485% |
Alpa Laboratories Limited | 184.49 Million INR | 45.636% |
Brooks Laboratories Limited | 14.44 Million INR | -594.598% |
AstraZeneca Pharma India Limited | 1.71 Billion INR | 94.16% |
Bajaj HealthCare Limited | - INR | -Infinity% |
Bliss GVS Pharma Limited | 1.23 Billion INR | 91.852% |
Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 99.852% |
Eris Lifesciences Limited | 5.18 Billion INR | 98.064% |
FDC Limited | 2.98 Billion INR | 96.641% |
Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 98.457% |
Gufic Biosciences Limited | 1.32 Billion INR | 92.458% |
Ind-Swift Laboratories Limited | 4.42 Billion INR | 97.731% |
Ipca Laboratories Limited | 7.98 Billion INR | 98.743% |
Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | 80.261% |
Krebs Biochemicals & Industries Limited | -151.95 Million INR | 166.006% |
Lasa Supergenerics Limited | -458 Million INR | 121.899% |
Laurus Labs Limited | 3.94 Billion INR | 97.46% |
Lupin Limited | 28.04 Billion INR | 99.642% |
Mankind Pharma Limited | 21.51 Billion INR | 99.534% |
Medicamen Biotech Limited | - INR | -Infinity% |
Megasoft Limited | -121.1 Million INR | 182.821% |
NATCO Pharma Limited | 25.96 Billion INR | 99.614% |
Piramal Pharma Limited | 4.55 Billion INR | 97.799% |
RPG Life Sciences Limited | 2.29 Billion INR | 95.624% |
Sigachi Industries Limited | 1.47 Billion INR | 93.195% |
Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 99.904% |
Suven Pharmaceuticals Limited | 4.6 Billion INR | 97.823% |
Syncom Formulations (India) Limited | 249.25 Million INR | 59.759% |
Unichem Laboratories Limited | - INR | -Infinity% |
Wanbury Limited | 569.71 Million INR | 82.395% |
Windlas Biotech Limited | 1.29 Billion INR | 92.278% |
ZIM Laboratories Limited | 253.82 Million INR | 60.485% |
Zydus Lifesciences Limited | 43.1 Billion INR | 99.767% |
Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 102.437% |
Divi's Laboratories Limited | 33.08 Billion INR | 99.697% |
Hester Biosciences Limited | 364.81 Million INR | 72.506% |
Procter & Gamble Health Limited | 2.78 Billion INR | 96.4% |
Amrutanjan Health Care Limited | 457.54 Million INR | 78.079% |
Bal Pharma Limited | 233.9 Million INR | 57.12% |
Strides Pharma Science Limited | 5.22 Billion INR | 98.081% |
Venus Remedies Limited | 534.65 Million INR | 81.24% |
Aarti Pharmalabs Limited | 3.12 Billion INR | 96.794% |
Nectar Lifesciences Limited | 923.8 Million INR | 89.143% |
Shilpa Medicare Limited | 1.36 Billion INR | 92.659% |
Aarti Drugs Limited | 7.14 Billion INR | 98.597% |
IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | 93.719% |
Suven Life Sciences Limited | -1.22 Billion INR | 108.182% |
Ind-Swift Limited | 1.22 Billion INR | 91.819% |
Valiant Laboratories Limited | - INR | -Infinity% |
J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 99.298% |
Solara Active Pharma Sciences Limited | -3.85 Billion INR | 102.603% |
Themis Medicare Limited | 392.58 Million INR | 74.452% |
Hikal Limited | 32.11 Million INR | -212.364% |
Torrent Pharmaceuticals Limited | 25.33 Billion INR | 99.604% |
Sequent Scientific Limited | - INR | -Infinity% |
Novartis India Limited | 626.5 Million INR | 83.99% |
Wockhardt Limited | -670 Million INR | 114.97% |
Jubilant Pharmova Limited | 5.18 Billion INR | 98.067% |
Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -1006.002% |
Neuland Laboratories Limited | 5.31 Billion INR | 98.114% |
Morepen Laboratories Limited | 4.17 Billion INR | 97.597% |
Kilitch Drugs (India) Limited | 208.05 Million INR | 51.79% |
Mangalam Drugs & Organics Limited | 27.45 Million INR | -265.285% |